Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Chugai Pharmaceutical is a leading Japanese biopharmaceutical company specializing in innovative medicines. The company focuses on the research, development, and commercialization of therapeutics for diseases with high unmet medical needs. Chugai advances groundbreaking science to offer new hope to patients worldwide and improve healthcare.
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Chugai Pharmaceutical is scheduled to report its next quarterly earnings on 10/27/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Chugai Pharmaceutical last reported quarterly earnings on 7/24/2026 (Q2 2026). Earnings per share (EPS) came in at 68.79 JPY.
Across its last 5 earnings reports, Chugai Pharmaceutical stock moved by ±1.7% on average the following day. The largest reaction was -3.1% on 10/24/2025; 1 of 5 reactions were positive.
Chugai Pharmaceutical has beaten analyst EPS estimates in 2 of its last 5 evaluated quarters (beat rate: 40%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 5 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.